V004-1141 Screening compound: 8-(2,4-difluorobenzoyl)-4-(4-methoxybenzoyl)-N-[(oxolan-2-yl)methyl]-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxamide

V004-1141 Screening compound: 8-(2,4-difluorobenzoyl)-4-(4-methoxybenzoyl)-N-[(oxolan-2-yl)methyl]-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxamide
V004-1141 Screening compound: 8-(2,4-difluorobenzoyl)-4-(4-methoxybenzoyl)-N-[(oxolan-2-yl)methyl]-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V004-1141
8-(2,4-difluorobenzoyl)-4-(4-methoxybenzoyl)-N-[(oxolan-2-yl)methyl]-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V004-1141

Molecular Formula

C28H31F2N3O6 (C28 H31 F2 N3 O6)

Compound Name

8-(2,4-difluorobenzoyl)-4-(4-methoxybenzoyl)-N-[(oxolan-2-yl)methyl]-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxamide

IUPAC name

8-(24-difluorobenzoyl)-4-(4-methoxybenzoyl)-N-[(oxolan-2-yl)methyl]-1-oxa-48-diazaspiro[4.5]decane-3-carboxamide

SMILES

COc(cc1)ccc1C(N1C(CC2)(CCN2C(c(ccc(F)c2)c2F)=O)OCC1C(NCC1OCCC1)=O)=O

InChI

InChI=1S/C28H31F2N3O6/c1-37-20-7-4-18(5-8-20)26(35)33-24(25(34)31-16-21-3-2-14-38-21)17-39-28(33)10-12-32(13-11-28)27(36)22-9-6-19(29)15-23(22)30/h4-9,15,21,24H,2-3,10-14,16-17H2,1H3,(H,31,34)

InChI Key

OYCDFDTXEXWMOB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19813843

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

543.57

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.050

Distribution Coefficient, logD

2.050

Water Solubility, LogSw

-2.95

Polar Surface Area

80.193

Acid Dissociation Constant (pKa)

14.20

Base Dissociation Constant (pKb)

-0.00

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

46.43

V004-1141 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Anti-HIV1 Library (19540 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V004-1141 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V004-1141?
Check Price and Availability of V004-1141, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V004-1141 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V004-1141
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V004-1141
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V004-1141 available by request